Leber's hereditary optic neuropathy associated with schizophrenia

Journal of Clinical Psychiatry

Volumn 73, Issue 9, 2012, Pages

  Boyer, Laurent ^a   Guedj, Eric ^b   Dassa, Daniel ^c   Lancon, Christophe ^a,d  

^a TIMONE HOSPITAL   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c La Conception University Hospital   (France)

^d HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CYSTEINE ETHYL ESTER TC 99M; RISPERIDONE;

ADULT; ARTICLE; BEHAVIOR DISORDER; BURNING SENSATION; CASE REPORT; ELECTROENCEPHALOGRAM; FAMILY HISTORY; GENE MUTATION; HEADACHE; HUMAN; LEBER HEREDITARY OPTIC NEUROPATHY; MALE; NEGATIVE SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETINA FLUORESCEIN ANGIOGRAPHY; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUBSTANCE ABUSE; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 84866494449     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.11cr07541     Document Type: Article

References (23)

1. Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science.1988;242(4884): 1427-1430. PubMed
2. McFarland R, Taylor RW, Turnbull DM. The neurology of mitochondrial DNA disease. Lancet Neurol. 2002;1(6):343-351. doi:10.1016/S1474-42(02)0159-X PubMed
3. Kovács GG, Höftberger R, Majtényi K, et al. Neuropathology of white matter disease in Leber's hereditary optic neuropathy. Brain. 2005; 128(pt 1):35-41. doi:10.1093/brain/awh310 PubMed
4. Morimoto N, Nagano I, Deguchi K, et al. Leber hereditary optic neuropathy with chorea and dementia resembling Huntington disease. Neurology. 2004;63(12):2451-2452. PubMed
5. Perez F, Anne O, Debruxelles S, et al. Leber's optic neuropathy associated with disseminated white matter disease: a case report and review. Clin Neurol Neurosurg. 2009;111(1):83-86. doi:10.1016/j.clineuro.208.06.021 PubMed
6. Fattal O, Budur K, Vaughan AJ, et al. Review of the literature on major mental disorders in adult patients with mitochondrial diseases. Psychosomatics. 2006;47(1):1-7. doi:10.176/api.psy.47.1.1 PubMed
7. Verge B, Alonso Y, Valero J, et al. Mitochondrial DNA (mtDNA) and schizophrenia. Eur Psychiatry. 2011;26(1):45-56. doi:10.1016/j.eurpsy.2010.08.08 PubMed
8. Guedj E, Barbeau EJ, Didic M, et al. Identification of subgroups in amnestic mild cognitive impairment. Neurology. 2006;67(2):356-358. doi:10.1212/01.wnl.025076.7312.d4 PubMed
9. Chinnery PF, Schon EA. Mitochondria. J Neurol Neurosurg Psychiatry. 2003;74(9):1188-1199. doi:10.136/jnp.74.9.18 PubMed
10. Orth M, Schapira AH. Mitochondria and degenerative disorders. Am J Med Genet. 2001;106(1):27-36. doi:10.102/ajmg.1425 PubMed
11. Shanske AL, Shanske S, DiMauro S. The other human genome. Arch Pediatr Adolesc Med. 2001;155(11):1210-1216. PubMed
12. Clay HB, Sillivan S, Konradi C. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int J Dev Neurosci. 2011;29(3): 311-324. doi:10.1016/j.ijdevneu.2010.08.07 PubMed
13. Maurer I, Zierz S, Möller H. Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia. Schizophr Res. 2001;48(1):125-136. doi:10.1016/S0920-964(0)075-X PubMed
14. Ben-Shachar D, Zuk R, Gazawi H, et al. Increased mitochondrial complex I activity in platelets of schizophrenic patients. Int J Neuropsychopharmacol. 1999;2(4):245-253. doi:10.1017/S1461457901649 PubMed
15. Karry R, Klein E, Ben Shachar D. Mitochondrial complex I subunits expression is altered in schizophrenia: a postmortem study. Biol Psychiatry. 2004;55(7):676-684. doi:10.1016/j.biopsych.203.12.012 PubMed
16. Rezin GT, Amboni G, Zugno AI, et al. Mitochondrial dysfunction and psychiatric disorders. Neurochem Res. 2009;34(6):1021-1029. doi:10.107/s1064-08- 9865-8 PubMed
17. Dror N, Klein E, Karry R, et al. State-dependent alterations in mitochondrial complex I activity in platelets: a potential peripheral marker for schizophrenia. Mol Psychiatry. 2002;7(9):995-1001. doi:10.1038/sj.mp.4016 PubMed
18. Rocca MA, Valsasina P, Pagani E, et al. Extra-visual functional and structural connection abnormalities in Leber's hereditary optic neuropathy. PLoS ONE. 2011;6(2):e17081. doi:10.1371/journal.pone.017081 PubMed
19. Kegeles LS, Humaran TJ, Mann JJ. In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy. Biol Psychiatry. 1998;44(6):382-398. doi:10.1016/S06-323(97)0425-3 PubMed
20. Volz HR, Riehemann S, Maurer I, et al. Reduced phosphodiesters and high-energy phosphates in the frontal lobe of schizophrenic patients: a (31)P chemical shift spectroscopic-imaging study. Biol Psychiatry. 2000;47(11):954-961. doi:10.1016/S06-323(0)0235-3 PubMed
21. Gonul AS, Kula M, Eşel E, et al. A Tc-99m HMPAO SPECT study of regional cerebral blood flow in drug-free schizophrenic patients with deficit and non-deficit syndrome. Psychiatry Res. 2003;123(3):199-205. doi:10.1016/S0925-4927(03)067-2 PubMed
22. Neustadt J, Pieczenik SR. Medication-induced mitochondrial damage and disease. Mol Nutr Food Res. 2008;52(7):780-788. doi:10.102/mnfr.207075 PubMed
23. Cakir Y, Yang Z, Knight CA, et al. Effect of alcohol and tobacco smoke on mtDNA damage and atherogenesis. Free Radic Biol Med. 2007;43(9): 1279-1288. doi:10.1016/j.freradbiomed.207.07.015 PubMed